Stage III Inflammatory Breast Cancer: Rhonda's Patient Story
This breast cancer diagnosis at a glance
- Stage at diagnosis
- Stage III
- Subtype
- Inflammatory Breast Cancer
- Sex
- Female
- Treatment
- chemotherapy
Treatment course, step by step
- After her September 2001 diagnosis, Rhonda received chemotherapy.
- Her cancer journey was followed by long-term health effects including lymphedema, heart disease, a stroke, and a heart attack.
What happened, in summary
In September 2001, Pastor Rhonda Holbert went to a routine medical appointment and underwent a needle biopsy. She was then told she had Stage III inflammatory breast cancer, a rare and aggressive form of breast cancer. She was alone when she received the diagnosis and relied on her faith in the days that followed.
Rhonda received chemotherapy after her diagnosis. Her cancer journey also brought serious long-term health effects, including lymphedema, heart disease, and later a stroke and heart attack. She has spoken openly about how survivorship can continue to affect health long after initial cancer treatment.
Her experience led to a lasting role in patient support. While receiving chemotherapy, Rhonda noticed that patients often lacked connection and encouragement, so she began checking on people and bringing them together. That effort grew into the Celebrate Life Cancer Ministry. She now helps people navigate treatment, keep appointments, find resources, and manage barriers such as referrals, insurance approvals, and delays in access to care.
For Rhonda, survivorship became more than living longer. It became a commitment to helping other people through cancer, combining faith, practical support, and advocacy for better access to care.
Where this story comes from
This is a lay summary of an account first published by AACR. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer